These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17785556)

  • 41. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma.
    Guerrero D; Guarch R; Ojer A; Casas JM; Ropero S; Mancha A; Pesce C; Lloveras B; Garcia-Bragado F; Puras A
    BJU Int; 2008 Sep; 102(6):747-55. PubMed ID: 18336597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues.
    Avraham A; Sandbank J; Yarom N; Shalom A; Karni T; Pappo I; Sella A; Fich A; Walfisch S; Gheber L; Evron E
    Epigenetics; 2010 Jan; 5(1):41-6. PubMed ID: 20083893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Avramouli A; Tsochas S; Mandala E; Katodritou E; Ioannou M; Ritis K; Speletas M
    Leuk Res; 2009 Aug; 33(8):1130-2. PubMed ID: 19193434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.
    Kvasha S; Gordiyuk V; Kondratov A; Ugryn D; Zgonnyk YM; Rynditch AV; Vozianov AF
    Cancer Lett; 2008 Jul; 265(2):250-7. PubMed ID: 18378390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
    Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
    Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
    Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
    Front Oncol; 2019; 9():394. PubMed ID: 31165042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
    Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
    Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
    Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
    Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia.
    Meyer S; White DJ; Will AM; Eden T; Sim A; Brown R; Strathdee G
    Br J Haematol; 2006 Jul; 134(1):61-3. PubMed ID: 16803569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 during monocyte-macrophage differentiation in THP-1 cells.
    Martino V; Bianchera A; Reia L; Bussolati O; Fazzina R; Marino F; Montemurro L; Tonelli R; Pession A; Gazzola GC; Sala R
    Mol Med Rep; 2009; 2(2):241-4. PubMed ID: 21475819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Abnormalities of the retinoblastoma susceptibility gene (RB) in hematologic malignancies].
    Furukawa Y
    Nihon Rinsho; 1992 Jun; 50(6):1347-52. PubMed ID: 1518156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA methylation changes in hematologic malignancies: biologic and clinical implications.
    Issa JP; Baylin SB; Herman JG
    Leukemia; 1997 Mar; 11 Suppl 1():S7-11. PubMed ID: 9130685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constitutive gene expression and restoration of the normal phenotype in malignant cells: a model for the origin and evolution of leukemia.
    Sachs L
    Blood Cells; 1981; 7(1):31-44. PubMed ID: 6964816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.